Researchers at Case Western Reserve discover a new way the body fights fungal infection

Jun 11, 2009

A team of researchers led by Amy G. Hise, M.D., M.P.H., assistant professor at the Center for Global Health and Diseases, Case Western Reserve University School of Medicine, is the first to discover how the body fights off oral yeast infections caused by the most common human fungal pathogen, Candida.

As become more resistant to current drugs, this groundbreaking research may directly lead to the development of new drugs and therapies that will help limit and/or prevent Candida infections in the future for millions of sufferers.

Candida albicans is the most common species of the Candida fungus and is the leading cause of vaginal and oral yeast infections, including thrush and denture stomatitis. It is the fourth most common hospital acquired bloodborne pathogen in the United States and surprisingly, it is present in the mouths of 30 to 50 percent of healthy adults.

Because of the widespread nature of Candida, the potential for overgrowth and infection is common in the young, elderly, immuno-compromised and people receiving corticosteroid or chemotherapy treatments.

The findings, published in Cell, Host and Microbe, identified the critical role of a protein, interleukin-1β or IL-1β, secreted by a variety of cells in the human immune system to protect the body from oral colonization by Candida albicans and preventing it from spreading to infect host tissue and blood. The study defines the precise mechanism by which the body's immune cells produce IL-1β following contact with Candida albicans. Further, it shows that a complex of proteins, collectively termed the NLRP3 inflammasome, function to produce IL-1β from an inactive, precursor form into a form that can be secreted by cells and subsequently function to modulate the immune system and its responses.

This research clarifies a number of mechanisms and pathways that may be therapeutic targets to help alleviate and/or eliminate Candida overgrowth and its accompanying symptoms, such as pain and discomfort, swelling, burning sensation of affected area, difficulty swallowing, in individuals suffering from infections.

The findings of Dr. Hise's laboratory will open many new avenues of research in fungal infections. One direction they are pursuing is to identify the way that the fungus activates the inflammasome. This might provide new targets for drug development. Another area of interest is the investigation of how small differences between individuals in immune related genes, called single nucleotide polymorphisms or SNPs, affect susceptibility to fungal and other infections.

"If we can identify patterns of SNPs that make people more likely to develop life-threatening fungal infections, it may be possible in the future to use these as markers to screen patients. For example, patients admitted to intensive care units or needing long-term invasive catheters could be genetically screened to identify who would benefit from preventive anti-fungal treatment," says Dr. Hise.

Source: Case Western Reserve University (news : web)

Explore further: The impact of bacteria in our guts

add to favorites email to friend print save as pdf

Related Stories

Voriconazole: A highly potent treatment for fungal infections

Dec 16, 2008

The effectiveness of voriconazole in combating fungal infections has been confirmed by a new study to be featured in the International Journal of Antimicrobial Agents, published by Elsevier. Fungal infections can kill people ...

Recommended for you

The impact of bacteria in our guts

Aug 22, 2014

The word metabolism gets tossed around a lot, but it means much more than whether you can go back to the buffet for seconds without worrying about your waistline. In fact, metabolism is the set of biochemical ...

Stem cell therapies hold promise, but obstacles remain

Aug 22, 2014

(Medical Xpress)—In an article appearing online today in the journal Science, a group of researchers, including University of Rochester neurologist Steve Goldman, M.D., Ph.D., review the potential and ch ...

New hope in fight against muscular dystrophy

Aug 22, 2014

Research at Stockholm's KTH Royal Institute of Technology offers hope to those who suffer from Duchenne muscular dystrophy, an incurable, debilitating disease that cuts young lives short.

Biologists reprogram skin cells to mimic rare disease

Aug 21, 2014

Johns Hopkins stem cell biologists have found a way to reprogram a patient's skin cells into cells that mimic and display many biological features of a rare genetic disorder called familial dysautonomia. ...

User comments : 2

Adjust slider to filter visible comments by rank

Display comments: newest first

E_L_Earnhardt
not rated yet Jun 12, 2009
A lot of very useful information could result from this study! Please keep us appraised of each discovery!
Sepp
not rated yet Jun 14, 2009
Since H2O2 or hydrogen peroxide kills the fungus, I wonder why the substance is not in wider use, for instance as a substitute for or an ingredient in toothpaste. I believe it would work wonders in keeping the candida population at manageable levels.

It's something we could do while waiting for that research to lead to some results - or maybe not.